Industry News
New research shows possibility of cure for HPV positive throat cancer patients
2/17/2015
Patients with cancer of the throat caused by the Human Papilloma virus (HPV+) have a better prognosis than those who are negative for the virus (HPV-).
Two cell-signaling molecules found to suppress the spread of melanoma
2/17/2015
Findings advance efforts to identify who would benefit from more aggressive therapy at earliest stagesIn what is believed to be the largest epigenetic analysis to date of cell-signaling molecules...
New research shows possibility of cure for HPV positive throat cancer patients
2/17/2015
Patients with cancer of the throat caused by the Human Papilloma virus (HPV+) have a better prognosis than those who are negative for the virus (HPV-).
Despite advances in melanoma treatment, many patients with unresectable, multiple or advanced locally/regionally metastatic stage IIIB/C or stage IV M1a melanoma will need several lines of therapy...
In recent months, several national initiatives for personalized medicine have been announced, including the recently launched precision medicine initiative in the US, driven by rapid advances in...
85 percent of patients with cancer of unknown origin matched to treatment using new gene test
2/16/2015
Foundation Medicine, Inc. has announced that new data utilizing FoundationOne was published in the inaugural issue of JAMA Oncology.
New radiotracer helps avoid neck dissection in patients with early head and neck cancer
2/16/2015
A new tracer can enable surgeons to make an accurate identification of the sentinel node - the lymph node to which cancer spreads first - and hence spare patients the post-operative complications...
Estimates of gastric, breast cancer risk in carriers of CDH1 gene mutations
2/16/2015
More precise estimates of age-associated risks of gastric and breast cancer were derived for carriers of the CDH1 gene mutation, a cancer predisposing gene that is abnormal in families meeting...
Despite advances in melanoma treatment, many patients with unresectable, multiple or advanced locally/regionally metastatic stage IIIB/C or stage IV M1a melanoma will need several lines of therapy...
Unlikely pairing - an antidepressant plus dye - yields tumor-targeting tool
2/16/2015
Scientists combine molecules to create a drug that finds and suppresses prostate cancer in miceA near-infrared dye targets tumors in a mouse.